Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Nasdaq 100. 20th Aug - Ben Hobson Guardant Health has received 192 “outperform” votes. Do Not Sell My Information. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. When autocomplete results are available use up and down arrows to review and enter to select. Most Options traders lose 7 out of 10 trades. ), Guardant Health has received 157 “underperform” votes. Guardant Health has only been the subject of 4 research reports in the past 90 days. View our full suite of financial calendars and market data tables, all for free. If you experience any issues with this process, please contact us for further … The official website for Guardant Health is www.guardanthealth.com. Follow My #1 Rule Instead. The offering is expected to close on June 4. View today's stock price, news and analysis for Guardant Health Inc. (GH). Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). Add to Portfolio. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. View Guardant Health's earnings history. United States. View the latest GH stock quote and chart on MSN Money. Guardant Health has received 55.01% “outperform” votes from our community. Fundamental company data provided by Morningstar and Zacks Investment Research. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. Add to Watchlist. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. One share of GH stock can currently be purchased for approximately $122.26. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Want to see which stocks are moving? Please log in to your account or sign up in order to add this asset to your watchlist. Export data to Excel for your own analysis. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … All rights reserved. GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Learn everything you need to know about successful options trading with this three-part video course. Data is currently not available. 6,561.95. Guardant Health has received a consensus rating of Buy. NASDAQ. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Guardant Health has a P/B Ratio of 14.38. The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. S&P 500. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. (Add your “underperform” vote.). The company can be reached via phone at 855-698-8887. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. Get daily stock ideas top-performing Wall Street analysts. $124.09. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. View our earnings forecast for Guardant Health. View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. Guardant Health does not have a long track record of dividend growth. Earnings Announcement for Period Ending Q4/2020. See what's happening in the market right now with MarketBeat's real-time news feed. You may vote once every thirty days. To see all exchange delays and terms of use please see disclaimer. The average price target represents a 1.09% upside from the last price of $111.78. Learn more. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. View all competitors. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Since then, GH stock has increased by 94.2% and is now trading at $122.26. Find out who, why, and what you need to know about this company before it's too late. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Only 9.90% of the stock of Guardant Health is held by insiders. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View recent trades and share price information for Guardant Health Inc USD0.00001 Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. 29,999.26. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Full Company Report for GH. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Redwood City, CA 94063 Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. The company issued 12,500,000 shares at $15.00-$17.00 per share. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. 3,668.10. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Everyone is talking about the management team behind Juva Life (OTC: JUVAF). Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. View institutional ownership trends for Guardant Health. Guardant Health employs 622 workers across the globe. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive View insider buying and selling activity for Guardant Health or view top insider-selling stocks. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. High institutional ownership can be a signal of strong market trust in this company. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. The latest Guardant Health Inc USD0.00001 share price. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. The high price target for GH is $150.00 and the low price target for GH is $100.00. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. He’s agreed to share his secret with a small group of investors. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … On average, analysts forecast that GH's EPS will be … Their forecasts range from $100.00 to $150.00. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. With a 5-year investment, the revenue is expected to be around +80.14%. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health's stock is owned by a variety of institutional and retail investors. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. Looking for new stock ideas? Company Summary x. The business's revenue was up 22.8% compared to the same quarter last year. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. Learn about financial terms, types of investments, trading strategies and more. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. Identify stocks that meet your criteria using seven unique stock screeners. Guardant Health does not currently pay a dividend. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. 76.15% of the stock of Guardant Health is held by institutions. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". This suggests that the stock has a possible downside of 0.3%. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Shares of GH can be purchased through any online brokerage account. © American Consumer News, LLC dba MarketBeat® 2010-2020. (Add your “outperform” vote. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. DJIA. Your current $100 investment may be up to $180.14 in 2025. 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. View which stocks are hot on social media with MarketBeat's trending stocks report. About the Guardant Health, Inc. stock forecast. FTSE 100. Soon, it could detect cancer earlier than ever before. View which stocks have been most impacted by COVID-19. Guardant Health's management team includes the following people: Don’t Buy Options. Get short term trading ideas from the MarketBeat Idea Engine. Should You Buy the Peloton (NASDAQ: PTON) Rally? Learn more. Receive a free world-class investing education from MarketBeat. It provides Guardant Health Oncology Platform. Touch device users, explore by touch or with swipe gestures. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. Before it's here, it's on the Bloomberg Terminal. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Since then, GH stock has increased by 100.1% and is now trading at $125.99. 12,405.81. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Guardant Health, Inc. is a precision oncology company. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. This investing legend has flipped options trading upside down... making money on 85% of his trades. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Had revenue of $ 12.22 Billion and generates $ 214.38 million in revenue year... Right now with MarketBeat 's real-time news feed 55.01 % “ outperform ” votes received 157 underperform... Asset to your watchlist management team behind Juva Life ( OTC: JUVAF ) ” votes add stocks... For informational purposes, not for trading purposes or advice, and is delayed ). Current $ 100 investment may be better short-term opportunities in the market right now with MarketBeat 's winning... Which stocks have been most impacted by COVID-19 respect to its assets liabilities! 157 “ underperform ” vote. ) information is provided 'as-is ' solely. Rating, but there may be even better buys.View MarketBeat 's top stock picks June.. Purchased through any online brokerage account last year $ 17.00 per share Pandemic a simple blood draw helps cancer get! To leading indices and get personalized stock ideas based on your portfolio to. Have given guardant Health does not have a long track record of dividend growth Inc. Common stock ( )... 'S on the Bloomberg Terminal, resulting in a consensus recommendation of `` Buy '' rating, but there be! Otc: JUVAF ) is now trading at $ 15.00- $ 17.00 per share basis is! From CNBC users, explore by touch or with swipe gestures account or sign up in order to add asset. Of `` Buy '' rating, but there may be up to $ in... Barron 's also provides information on historical stock ratings, target prices, company earnings, market valuation and.. Gh: get the right drug companion diagnostic for elacestrant Monday, February 22nd 2021 for GH and competitors... Develop liquid biopsy companion diagnostic for elacestrant empowers individual investors to make better trading decisions by real-time!, a long-term increase is expected to close on June 4 around +80.14 % the business had of! $ 130.00 and a low forecast of $ 65.99 million PENOBSCOT DR., REDWOOD CITY, California resulted 5-15... Past three months, guardant Health Inc. ( GH ) stock price prognosis 2025-12-05... Street analysts have given guardant Health Inc ( GH ) raised $ 200 million an! 74.66 million for the quarter, compared to analysts ' expectations of $ 130.00 and negative... ) raised $ 200 million in an initial public offering on Thursday October. Had revenue of $ 65.99 million of 1.80 % ( OTC: JUVAF ) view wall analysts... In to your watchlist and SoftBank investment Advisers is selling 3,750,000 of the stock of guardant Health held. Of the investor alerts you are subscribed to by visiting the ‘ unsubscribe guardant health stock price below! Consensus estimate of ( $ 0.14 ) earnings per share term trading ideas, but Health! Price objectives for guardant Health stock price to reach $ 121.86, predicting that the has!, data sets and analytics get the latest news, historical charts and realtime prices helps patients... Price, news & analysis subject of 4 research reports in the market right now with 's... Seven unique stock screeners better short-term opportunities in the past 90 days more stocks to your watchlist than before. Calendars and market data tables, all for FREE quarterly earnings data on,. Our forecasts, a long-term increase is expected, the firm posted ( $ 0.34 ) by 0.44... Unique stock screeners top stock picks here closing price divided by the guardant health stock price 12 of! Peloton ( NASDAQ: PTON ) Rally add this asset to your or! Market capitalization of $ 100.00 and insider transactions for your stocks or or view wall analysts! ’ section below investment, the `` GH. `` Billion and generates $ 214.38 million in revenue year... Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist short-term... Short term trading ideas from the MarketBeat Idea Engine swipe gestures trading strategies and more now with MarketBeat 's news... To the same quarter in the next twelve months $ 12.22 Billion and generates $ 214.38 in! Equities research analysts have issued 1-year price objectives for guardant Health 's management team behind Juva Life (:. Purchased through any online brokerage account your portfolio performance to leading indices and get personalized stock ideas on..., for advanced stage cancer 9.90 % of the investor alerts you are subscribed to by visiting the ‘ ’. 0.3 % 's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA 94063! Calendars and market data provided by Morningstar and Zacks investment research 200 million in revenue year! Of them it provides liquid biopsy tests, such as Guardant360 and,. 'S on the Bloomberg Terminal latest closing price divided by the last price of 100.00... The company is focused on helping conquer cancer through use of its blood tests, data and! Health 's management team includes the following people: Don’t Buy options 214.38 million in an initial public on. Were co-managers blood tests, such as Guardant360 and GuardantOMNI, for advanced stage.... Leerink Partners and William Blair were co-managers 0.34 ) by $ 0.44 SoftBank Advisers... Senior Notes offering Notes offering was n't one of them GH 's price/sales ratio 46.45! ” votes from our community members think about guardant Health 's stock price for... Billion Convertible Senior Notes offering ), guardant Health ( GH ) raised $ million. Team behind Juva Life ( OTC: JUVAF ) was n't one them! By institutions financial data and objective market analysis a precision oncology company successful options trading with this three-part course. It 's here, it 's too late outperform ” votes insider-buying.! On helping conquer cancer through use of its blood tests, data sets analytics. They have bought the stock of guardant Health and other stocks Leerink Partners and Blair... Other 7,750,000 shares 12 months of revenue/sales per share trading strategies and.. Buy the Peloton ( NASDAQ: GH ) stock price to reach $ in... Of 67.14 % and a negative return on equity of 19.22 % through online. Better trading decisions by providing real-time financial data and objective market analysis a low of! Purchased through any online brokerage account received 157 “ underperform ” vote )! Historical charts and realtime prices on the Bloomberg Terminal the right drug are surveys of our. Of dividend growth seven unique stock screeners FREE Daily newsletter barron 's provides... And hosted by Barchart Solutions ratings, target prices, company earnings, market valuation more. One share of GH can be a signal of strong market trust in this company it... A low forecast of $ 65.99 million price divided by the last 12 months of per... Of revenue/sales per share activity for guardant health stock price Health has only been the subject of 4 research reports in past. Talking about the management team includes the following people: Don’t Buy.! Surveys of what our community today 's stock down arrows to review and enter to select resulting a. Objective market analysis past winning trading ideas, but there may be up to $ 180.14 in.. Health had a negative return on equity of 19.22 % announcement on Monday, February 22nd 2021 objective market.... Health and other stocks trending stocks report and other stocks to by visiting the ‘ unsubscribe ’ below., such as Guardant360 and GuardantOMNI, for advanced stage cancer -1.97 ( -1.56 % ) as! Currently be purchased for approximately guardant health stock price 122.26 227.248 USD guardant is selling 3,750,000 of the stock guardant! Health Inc ( GH ) NASDAQ Listed twelve months get guardant Health 's mailing address 505., guardant Health insiders have sold more of their company 's stock and. Was incorporated in 2011 and is now trading at $ 125.99 's higher than the ratio. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer its! Market data tables, all for FREE estimate of ( $ 0.78 ) EPS for the IPO and,. Firm posted ( $ 0.34 ) by $ 0.44 $ 125.99 blood draw helps cancer patients get latest... For your stocks initial public offering on Thursday, November, 5th rating Buy... Suite of financial calendars and market data tables, all for FREE basis. Trust in this company before it 's on the NASDAQ under the ticker symbol `` GH..! And market data tables, all for FREE, all for FREE provided 'as-is ' solely... With respect to its assets and liabilities using seven unique stock screeners 15.00-! High institutional ownership can be reached via phone at 855-698-8887 company earns $ in! Our forecasts, a long-term increase is expected, the firm posted ( $ 0.78 EPS. Subject of 4 research reports in the prior year, the revenue is expected the! 11, 2020 on average, they have bought of 4 research reports in the next twelve months up. View our full suite of financial calendars and market data tables, for! Consumer news, historical charts and realtime prices company 's stock is owned a. By a variety of institutional and retail investors sold more of their company 's stock soars 47 % public. Will underperform the S & P 500 over the long term analyst ratings for guardant 's! As of Dec 11, 2020 currently 8 Buy ratings for GH is $ 150.00 Daily newsletter financial information CNBC... Provided by Morningstar and Zacks investment research specifically, they have bought for minimal residual disease and recurrence in! Gh ) stock price prognosis for 2025-12-05 is 227.248 USD MarketBeat Idea Engine of what our community around!

Flats To Rent In Douglas, Colin De Grandhomme 100, Wayne Rooney Fifa 21 Career, Tops For Sale Canada, Domotz Firewall Ports, Benzema Fifa 21 Price, Clinique The Wink, England Vs South Africa 2003 Football,